Glanatec ophthalmic solution 0.4% eye drops (glaucoma Ripasudil, Rho kinase)

General data on Glanatec ophthalmic solution from Japan for the treatment of glaucoma.

Package details: 5 bottles of 5 ml.

Manufacturer: Kowa Pharmaceuticals, Japan.

Active ingredient: Ripasudil hydrochloride hydrate (chemical formula C15H18FN3O2S).

Medical effect: This medicine effectively inhibits the Rho-kinase protein. Also, this eye drops contribute to the drainage of moisture and enhance the outflow of fluid from the eye ball. This medicine helps to effectively reduce intraocular pressure (eye hypertension). Glanatec is used to treat glaucoma and intraocular pressure.

Dosage and Administration:

• Adults apply 1 drop twice a day. If it is necessary to use other drops, wait at least five minutes after using Glanatec. Strictly follow these instructions.
• The dosage may be adjusted depending on the disease, age and symptoms. If you missed one dose, take the remedy as soon as possible. However, if the time of the next intake is approaching - just release the dose.
• Be sure to follow the instructions and instructions of the doctor.

Contraindications, precautions: In 0.9% of clinical trials, allergic reactions were observed. Primarily they included conjunctivitis, blepharitis, and eye irritation. Keep eye drops out of the reach of children in a cool dark place. Never expose to heat or sunlight.

Storage instructions:  Unopened bottles can be stored at room temperature (if not exceeds 28 Celsius for a long time), once opened, a bottle must be stored in the fridge. Make sure it does not get frozen. One opened bottle must be used within one month, if not finished, please dispose of it.

How effective is Glanatec from Japan for treatment of glaucoma?

Glanatec ophthalmic solution eye drop manufactured in Japan by the Kowa corporation is widely used for the supportive treatment of glaucoma and the reduction of eye hypertension (intraocular pressure). Full-scale clinical studies were conducted on patients with glaucoma and ocular hypertension in Japan in order to confirm the effectiveness of treatment of glaucoma and ocular hypertension (intraocular pressure). This medicine was certified and launched for sale in December 2014 in Japan. The brand name of the product is GLANATEC Ophthalmic Solution 0.4% (generic name: ripasudil chloride hydrate). The first international drug certification application was filed in Korea by Kowa Co., Ltd. in December 2017. After conducting the relevant tests, the application was approved in February 2019 and Glanatec was also approved for sale in Korea. This eye drops have proven medical effect and are officially certified medicine for glaucoma and intraocular pressure. According to clinical studies data, many fundamental scientific studies proved high effects for the treatment of the following clinical conditions:

1. Glaucoma
2. Increased intraocular pressure
3. Obstructed outflow of fluid from the eye
4. Symptoms associated with glaucoma.

This medicine has officially passed all safety tests, and is acceptable for use within the specified framework by the majority of patients.

Who should apply Glanatec eye drops from Japan?

It is suitable for patients who experience progressive glaucoma symptoms and severe cases. Glanatec is used in cases where other treatment may not be effective enough. The mechanism of action of this medicine is designed for the treatment of glaucoma using the impact on the biological mechanisms of fluid drainage from the eyeball. These innovative mechanisms make this drug effective for reducing ocular hypertension, or excessive pressure inside the eyeball.